InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the full record of transactions filed by Johnson John Paul, 首席财务官. Officer active across 1 company, notably Evolent Health, Inc.. Aggregated, 10 reports have been published. Breakdown: 0 buy · 2 sells. Total volume traded: €1.8m. Activity tracked since 1 March 2022. The latest transaction was filed on 1 July 2025 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 条申报中的 10 条
Johnson John Paul is Chief Financial Officer at Evolent Health, Inc. He has 10 filings, and across the 10 sampled filings from 2022-03-03 to 2025-07-03, reported sales total 1823708 EUR and the modal transaction nature is Attribution.